The beneficial effect of splenectomy in hereditary spherocytosis is well recognized. Selective retention of spherocytes in the spleens of patients with congenital hemolytic anemia was reported by Emerson, Shen, and Castle in 1946 (1) . Subsequently, spherocyte "trapping" was demonstrated in spleens removed from patients without this disorder (2, 3) . In addition, these abnormal red cells in the spleen have greater osmotic fragility than those in the peripheral blood (1) . Ham and Castle first postulated that the spleen increased the osmotic fragility of red cells by intravascular stasis in a manner similar to that produced by sterile incubation of blood (47) . Recently it has been suggested that the spleen "conditions" spherocytes for early osmotic hemolysis or increases their susceptibility to destruction by the mechanical forces of the circulation (8, 9) . Although exact mechanisms of spherocyte destruction remain obscure, splenectomy in congenital hemolytic anemia alleviates the hemolytic process.
The role of the spleen in red cell destruction in acquired hemolytic anemia is less thoroughly understood. Splenic hemosiderosis, erythrophagocytosis, and congestion with red cells suggest the importance of red cell sequestration by this organ in the pathogenesis of many of the acquired hemolytic anemias. The first good response to splenectomy was reported by Micheli in 1911 (10) . This operation has since been performed with unpredictable results in diseases having little in com-mon other than hemolytic anemia. Criteria for predicting a favorable result from splenectomy in acquired, or autoimmune, hemolytic anemia have not been provided by conventional laboratory aids.
Determination of relative organ distribution of radioactive erythrocytes is feasible by external scintillation counting (11) . Jandl, Greenberg, Yonemoto, and Castle have reported a method for determining organ sites of red cell sequestration using Cr5l-labelled erythrocytes (12, 13) . They reported splenectomy was beneficial in one patient who had splenic accumulation of labelled red cells.
A method of determining organ localization of Cr51-labelled red cells utilizing the ratio spleen: liver radioactivity as estimated by external scintillation counting was reported from this laboratory in 1955 (14) . It was assumed that a high splenic uptake of radioactivity concomitant with an increased rate of Crp5 red cell disappearance from the peripheral blood was evidence for abnormal red cell accumulation in the spleen. The present report of red cell survivals and organ counting data was derived from 27 labelled red cell infusions. Splenic uptake of radioactivity in hemolytic anemia was correlated with response to splenectomy.
MATERIALS AND METHODS

Conventional laboratory data
In patients suspected of hemolytic anemia, determinations of hemoglobin, reticulocytes, hematocrit, red blood cell count, red cell fragilities (15) , and serum bilirubin (16, 17) were performed by established techniques. The method of Dacie was used for the determination of autohemolysis of red cells (18) . Erythroid: myeloid ratios were computed after counting 1,000 nucleated cells in the bone marrow smear. Average fecal urobilinogen in a four-day stool collection was determined by the method of Watson (19) , using a Coleman junior colorimeter. One stool urobilinogen determination was semiquantitative (20) . When further uptake of Cr" by red cells (21) . A single washing procedure, using cold sterile saline, was done as follows: The mixture was centrifuged and the supernatant plasma was removed. The red cells were washed once with saline and finally diluted with saline to a volume approximating that of the whole blood withdrawn. These infusions were designated "washed." The washing procedure removed Cr" which was not bound to erythrocytes so that more than 97 per cent of Cr" infused was red-cell bound. In some instances the blood was not washed and such infusions were designated "non-washed." Cr"-labelled red cells were given intravenously through an 18-gauge needle by gravity drip from the collecting bottle or in 50-ml. volumes by calibrated syringe.
B. Determination of Cr" red cell surival. Al samples of peripheral blood were collected in balanced oxalate (15) With the exception of Patient N. A., all subjects with acquired hemolytic anemia were given adrenal steroids prior to splenectomy without significant benefit. We have hesitated to advise splenectomy for acquired hemolytic anemia when the process was controlled by steroids.
RESULTS
Initial data on patients with hemolytic anemia
Pertinent clinical features and laboratory data on the 14 patients showing evidence for hemolytic anemia are presented in Table I . The final diagnosis for each subject is entered in Table I for completion, but was not made in all patients prior to labelled erythrocyte studies. All subjects but N. H. and L. H. had increased (> 280 mg. per day) fecal urobilinogen. The osmotic fragility of red cells after incubation was abnormally increased in patients with hereditary spherocytosis. Increases in mean fragility upon incubation were not seen consistently in patients with acquired hemolytic anemia. Autohemolysis after 48 hours of sterile incubation was strikingly increased in hereditary spherocytosis and in the one subject (A. K.) with paroxysmal nocturnal hemoglobinuria. In acquired hemolytic anemia the degree of autohemolysis varied within wide limits from normal to abnormal. Mechanical fragility was regularly increased only in the hereditary spherocytosis group.
Cr5l red cell survival and organ counting Table II) . Homologous normal and autologous (spherocyte) studies are shown in the upper plots. The homologous normal red cell data is shown on the left. The patient suffered an infection between the 18th and 25th days of this study coincident with a fall in hematocrit. The drop in the red cell survival curve at this time produced a red cell half-life slightly less than normal (22 days). After recovery the curve became normal. On the right is shown the autologous (spherocyte) plot. The red cell halflife was grossly reduced concomitant with a rapid accumulation of splenic radioactivity. This study was terminated by splenectomy on the 12th day after infusion.
Recipient V. H. (Studies No. 13 and-14- Table II) . Autologous studies before and after splenectomy are shown in the lower plots. The pre-splenectomy study plotted on the left demonstrates only a slight early rise in the spleen: liver radioactivity ratio. The average ratio was not B. Splenomegaly without hemolytic anemia. These studies are illustrated in Figure 4 . In recipient J. K. (polycythemia vera in remission), the Crl red cell half-life was 27 days, and the average spleen: liver radioactivity ratio was 2.8. Patient L. K. had myelofibrosis without anemia. The Crl1 red cell half-life was 27 days, and the average spleen: liver radioactivity ratio was 1.8. A very slight increase in ratios occurred concomitant with the disappearance of labelled red cells from the peripheral blood in both of these subjects.
C. Congenital hemolytic anemia. For the observations shown in Figure 2 , Subjects L. R. (congenital hemolytic anemia) and D. H. (normal) served a dual role, i.e., as autologous and reciprocal homologous recipients of Cr"l red cells (Table II -Studies 5, 6, 9, 10). Labelled spherocytes infused into a normal person or back into the donor were rapidly eliminated from the peripheral circulation, and the spleen Crl1: liver Crl ratios increased to abnormally high levels. In contrast were the normal survival of normal red cells in the same subjects.
Three other subjects with congenital hemolytic anemia were studied (E. Z., V. H., N. H.- Tables  I and II, Figures 3 and 3a) .
D. Paroxysmal nocturnal hemoglobinuria. One patient with paroxysmal nocturnal hemoglobinuria was studied. Initial data (Subject A. K., Table  I ) indicated a moderately severe hemolytic anemia. There was a mild thrombopenia and leukopenia. There has been no gross hemoglobinuria. Studies with radioactive red cells are shown in Figure 5 . The Patient L. Y., with chronic lymphocytic leukemia, had the most severe hemolytic anemia (Table  I) . Daily blood transfusions were necessary to maintain a stable hematocrit. Labelled red cell studies are shown in Figure 9 . The scale used in this graph is enlarged so that the rapid changes may be clearly seen. The 50 per cent survival of Crl-labelled red cells from a normal donor was less than one day. With the rapid decline in the peripheral blood radioactivity there was an approximately reciprocal rise in the spleen Cr1:
liver Cr"5 ratio. The average ratio of spleen to liver radioactivity was 6.4.
Splenectomy
The effect of splenectomy upon the hemolytic process in eight patients is given in Table III Figure 3 ) had a normal autologous Cr51 red cell survival after splenectomy. Each of the five patients with acquired hemolytic anemia benefitting from splenectomy had an average spleen: liver radioactivity ratio of 3.0 or higher following the infusion of Cr51-labelled red cells. Probably more important than the average ratio is evidence for a rising ratio of spleen: liver radioactivity, suggesting selective splenic trapping of red cells. Data from Patients N. A. (Figure 6 ), J. L. (Figure 8) , and L. Y. (Figure  9 ) show striking evidence of increasing splenic radioactivity as compared to the liver during the period of rapid removal of labelled red cells from the circulation. Studies on W. M. (Figure 6 ) show a high initial spleen: liver radioactivity ratio, but this point was obtained 12 hours after the infusion of cells and may not be representative of earlier splenic radioactivity. The data from Patient L. H. (Figure 6 ) are suggestive of splenic accumulation of trapped red cells, but we lack data for the first several days of the study. In contrast, Patient J. T. (Figure 7) had an average ratio of 1.9 and was not improved by splenectomy. There was no evidence of a rising spleen: liver radioactivity ratio in this patient.
The results given in Table III (chronic lymphatic leukemia), whose hemolysis was so severe as to require daily blood transfusions, was dramatically relieved by splenectomy. There was no evidence for hemolytic anemia when this patient was seen in the hospital a few days prior to his death three and one-half months postoperatively.
DISCUSSION
The technique of red cell labelling and estimating erythrocyte survival with radioactive chromium used in this study is similar to that employed by Ebaugh, Emerson and Ross (22 Table II ). Patient J. T. received his own labelled red cells and is illustrated on the right. The red cell survival was reduced (half-life, 15 days), and there was no indication from spleen Cry: liver Cr" ratios for splenic sequestration of labelled erythrocytes. This patient did not benefit from splenectomy. which assumes a constant whole blood volume. It is believed this method gives a better estimation of Cr51 red cell survival than techniques based on measurements of radioactivity per unit volume of packed cells. The latter method assumes a constant red cell volume, an assumption which may not be correct in hemolytic states (23) .
There are many errors involved in the estimation of relative organ radioactivity by external monitoring of gamma emissions. Variations in counter positioning, counter-to-source distance, organ size, and radioactivity in adjacent viscera all affect the results. We have estimated the anatomic center of the surface projection of the liver and spleen by percussion, and, by using external landmarks, repositioned the probe at the same area in subsequent observations. Particular care must be employed in positioning the detector over the smaller organ (e.g., small spleen). If the approximate center is not located or there are moderate variations in day-to-day positioning, relatively large errors may be made in evaluating organ radioactivity. There are geometric limits of radioactivity accepted by the scintillator at close range. Consequently, less radioactivity is detectable over the large organ as compared to the small one, even though both contain equal quantities of isotope. This problem can theoretically be solved by normal donor. The data are shown in the lower left graph. There was a rapidly rising spleen Cry: liver Cr" ratio concomitant with a rapid rate of Cr" red cell removal from the peripheral blood. This patient responded well to splenectomy but 14 months later the clinical features of acute leukemia led to his demise.
Recipient W. M. (Study No. 21- Table II) . This patient had chronic lymphatic leukemia with an acquired hemolytic anemia. The survival of Cr"-labelled red cells from a normal donor was grossly reduced (half-life, 6 days). There was an associated rise in spleen Cr": liver Cr" ratio (average ratio, 3.5). This patient had an excellent response to splenectomy. He has had no treatment or anemia during the two and one-half years since. increasing the counter to source distance; however, without elaborate shielding apparatus, specificity of organ radioactivity is lost. Organ areas have been counted with an unshielded probe touching the skin, assuming this procedure would give valid data.
There is evidence that not all of the Cr5' found in the spleen after the infusion of labelled red cells is hemoglobin bound (24) . It is considered unlikely, however, that such radioactivity is derived from sources other than Cr5l-labelled red cells destroyed in the spleen. Cr5lCl3 (13, 25) and Crl-labelled hemoglobin infusions (13) showing low flat curves of splenic radioactivity support this conjecture.
In Figure 10 , average spleen to liver radioactivity ratios in acquired hemolytic anemia patients were grouped according to splenectomy response and compared with the ratios obtained in normal and splenomegalic subjects not demonstrating hemolytic mechanisms. The latter group noted by an asterisk in Figure 10 includes average organ radioactivity ratios from Studies 6 to 8, 11 and 25, Table II . Average ratios of spleen: liver radioactivity in the five normal subjects receiving labelled normal red cells ranged from 0.9 to 1.8. The higher ratios of spleen: liver radioactivity in splenomegalic subjects without hemolytic anemia are presumptive evidence for a greater labelled red cell volume "seen" by the detector over the larger organ. These studies provided control observations. From these data it appears that patients with reduced Cr5' red cell survival and a rising or high spleen: liver radioactivity ratio will have a favorable response to splenectomy. Obviously many more patients will have to be studied by predict a failure to benefit from removal of the spleen. The data are considered evidence in favor of the theory that splenectomy will be beneficial in those patients demonstrating selective splenic sequestration of erythrocytes. We have no data from patients with acquired hemolytic anemia without detectable splenomegaly (Table II) , and have studied only the one patient (J. T.- Table III ) with minimal splenomegaly who had splenectomy. However, it is likely that patients with acquired hemolytic anemia, red cell sequestration in the spleen and normal spleen size (should these features co-exist) would show spleen: liver radioactivity ratios similar to that in subjects without splenomegaly infused with labelled spherocytes (Figures 2 and 3a) . We are unable to explain the failure to demonstrate Cr11-lablled spherocyte accumulation in the spleen of the patient with hemolytic anemia without splenomegaly (V. H.- Figure 3 ).
Cr5l-labelled erythrocyte studies, in addition to the estimation of organ accumulation of red cells, may occasionally suggest mechanisms of hemolytic disease previously unsuspected. Clinical evaluation of Patient A. K. had indicated a brisk hemolytic anemia, mild thrombopenia and leukopenia. Splenectomy might have been advised-for "hypersplenism" had not erythrocyte survival studies indicated an intracorpuscular defect ( Figure 5 ). There was no evidence for congenital hemolytic anemia (Table I) , and the acid hemolysis test was unequivocally positive establishing the diagnosis of paroxysmal nocturnal hemoglobinuria. Organ radioactivity ratios in this patient did not suggest splenic accumulation of autologous or homologous erythrocytes. These studies are in accord with the usual observation that patients with this disorder are not helped by splenectomy (18) . On the other hand, Jandl and his colleagues have reported that splenectomy was beneficial in a patient with this disorder in whom splenic sequestration of autologous Cr51-labelled red cells had been demonstrated (13) .
Studies with radioactive red cells in Patient J. L. were of particular interest. This patient had severe hemolytic anemia of unknown type. The survival of "homologous" normal Cr51-labelled red cells was normal. The relatively marked rise of the spleen: liver radioactivity ratio during this study (Figure 8) Prior to labelled red cell studies, our laboratory data in acquired hemolytic anemia did not provide criteria for predicting response to splenectomy. This observation is in accord with that recently reported by Chertkow and Dacie (26) . Gross splenomegaly, however, was common to all patients with acquired hemolytic anemia showing evidence for splenic accumulation of Cr5l-labelled red cells. Patients with acquired hemolytic anemia and splenic sequestration of labelled red cells did not have spherocytosis in the peripheral blood as judged by osmotic fragility studies.
SUMMARY
The ratio spleen: liver radioactivity as determined by external scintillation counting after the infusion of Cr51-labelled erythrocytes has been used to determine organ localization of red cells in seven control subjects and 14 patients with hemolytic anemia. As anticipated, the spleen accumulated radioactivity rapidly following the transfusion of labelled spherocytes. Some patients with acquired hemolytic anemia showed gross evidence of trapping of radioactive red cells in their spleen. Removal of the spleen in five such patients was beneficial in each. One patient who showed no evidence for splenic trapping of red cells was splenectomized without beneficial effects on the 1484 'a hemolytic process. The method described is considered a useful aid in the selection of patients whose hemolytic process will be benefitted by splenectomy.
